Podoplanin as a marker for mesothelioma
Top Cited Papers
- 4 February 2005
- journal article
- Published by Wiley in Pathology International
- Vol. 55 (2) , 83-86
- https://doi.org/10.1111/j.1440-1827.2005.01791.x
Abstract
Podoplanin is a specific marker for lymph vessel endothelial cells. It was noted that podoplanin is expressed in reactive mesothelial cells. The utility of podoplanin for the histological diagnosis of tumors was then investigated, especially for mesothelioma. Immunohistochemical study of podoplanin was carried out in five malignant mesotheliomas and 118 other tumors including 93 adenocarcinomas, four squamous cell carcinomas, six gastrointestinal stromal tumors and five endocrine tumors. Immunoreactivity for podoplanin was demonstrated on the cell membrane of tumor cells for all mesotheliomas. All other tumors were negative for podoplanin. Among the many antibodies used for differential diagnosis of malignant mesothelioma, podoplanin has the potential to be an excellent tumor marker in both specificity and sensitivity. The utility of podoplanin as a marker for mesothelioma will be confirmed by further studies.Keywords
This publication has 11 references indexed in Scilit:
- Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progressionLaboratory Investigation, 2004
- Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymomaHuman Pathology, 2003
- Expression of vascular endothelial growth factor‐C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancerJournal of Oral Pathology & Medicine, 2003
- The Immunohistochemical Diagnosis of MesotheliomaThe American Journal of Surgical Pathology, 2003
- Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different TypesThe American Journal of Surgical Pathology, 2003
- Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinomaHuman Pathology, 2001
- Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung AdenocarcinomaThe American Journal of Surgical Pathology, 2001
- Intrapericardial lymphangioma with podoplanin immunohistochemical characterization of lymphatic endothelial cellsHistopathology, 2000
- Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the PleuraLaboratory Investigation, 2000
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999